CVAC logo

CureVac N.V. (CVAC) EBIT

annual EBIT:

$206.60M+$488.04M(+173.41%)
December 31, 2024

Summary

  • As of today (September 10, 2025), CVAC annual earnings before interest & taxes is $206.60 million, with the most recent change of +$488.04 million (+173.41%) on December 31, 2024.
  • During the last 3 years, CVAC annual EBIT has risen by +$682.43 million (+143.42%).
  • CVAC annual EBIT is now at all-time high.

Performance

CVAC EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCVACincome statement metrics

quarterly EBIT:

-$57.83M-$4.44M(-8.33%)
March 31, 2025

Summary

  • As of today (September 10, 2025), CVAC quarterly earnings before interest & taxes is -$57.83 million, with the most recent change of -$4.44 million (-8.33%) on March 31, 2025.
  • Over the past year, CVAC quarterly EBIT has increased by +$25.98 million (+31.00%).
  • CVAC quarterly EBIT is now -113.04% below its all-time high of $443.54 million, reached on September 30, 2024.

Performance

CVAC quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCVACincome statement metrics

TTM EBIT:

$252.33M+$25.98M(+11.48%)
March 31, 2025

Summary

  • As of today (September 10, 2025), CVAC TTM earnings before interest & taxes is $252.33 million, with the most recent change of +$25.98 million (+11.48%) on March 31, 2025.
  • Over the past year, CVAC TTM EBIT has increased by +$574.49 million (+178.32%).
  • CVAC TTM EBIT is now at all-time high.

Performance

CVAC TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCVACincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

CVAC EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+173.4%+31.0%+178.3%
3 y3 years+143.4%-6.3%+122.5%
5 y5 years+287.0%-109.3%+767.6%

CVAC EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+143.4%-113.0%+53.9%at high+125.8%
5 y5-yearat high+143.4%-113.0%+91.3%at high+120.5%
alltimeall timeat high+143.4%-113.0%+91.3%at high+120.5%

CVAC EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$57.83M(+8.3%)
$252.33M(+11.5%)
Dec 2024
$206.60M(-173.4%)
-$53.38M(-112.0%)
$226.35M(+25.8%)
Sep 2024
-
$443.54M(-654.4%)
$179.96M(-155.7%)
Jun 2024
-
-$80.00M(-4.5%)
-$322.94M(+0.2%)
Mar 2024
-
-$83.81M(-16.0%)
-$322.16M(+5.7%)
Dec 2023
-$281.44M(+8.1%)
-$99.78M(+68.1%)
-$304.74M(-7.8%)
Sep 2023
-
-$59.35M(-25.1%)
-$330.50M(+1.9%)
Jun 2023
-
-$79.23M(+19.4%)
-$324.23M(+4.3%)
Mar 2023
-
-$66.38M(-47.1%)
-$310.81M(+4.0%)
Dec 2022
-$260.33M(-45.3%)
-$125.55M(+136.5%)
-$298.82M(-64.3%)
Sep 2022
-
-$53.08M(-19.3%)
-$836.33M(-14.4%)
Jun 2022
-
-$65.80M(+21.0%)
-$977.13M(-13.1%)
Mar 2022
-
-$54.39M(-91.8%)
-$1.12B(-8.6%)
Dec 2021
-$475.83M
-$663.06M(+242.0%)
-$1.23B(+93.2%)
Sep 2021
-
-$193.88M(-8.7%)
-$636.08M(+29.9%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$212.46M(+33.2%)
-$489.66M(+70.4%)
Mar 2021
-
-$159.54M(+127.3%)
-$287.36M(+84.9%)
Dec 2020
-$123.05M(+11.4%)
-$70.20M(+47.9%)
-$155.45M(+82.3%)
Sep 2020
-
-$47.46M(+367.1%)
-$85.25M(+125.6%)
Jun 2020
-
-$10.16M(-63.2%)
-$37.79M(+36.8%)
Mar 2020
-
-$27.63M(<-9900.0%)
-$27.63M(+8.9%)
Dec 2019
-$110.46M(+32.0%)
$0.00(0.0%)
-$25.38M(0.0%)
Sep 2019
-
$0.00(0.0%)
-$25.38M(0.0%)
Jun 2019
-
$0.00(-100.0%)
-$25.38M(0.0%)
Mar 2019
-
-$25.38M(<-9900.0%)
-$25.38M(<-9900.0%)
Dec 2018
-$83.67M
-
-
Dec 2018
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2018
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2018
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2018
-
$0.00
$0.00

FAQ

  • What is CureVac N.V. annual earnings before interest & taxes?
  • What is the all time high annual EBIT for CureVac N.V.?
  • What is CureVac N.V. annual EBIT year-on-year change?
  • What is CureVac N.V. quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for CureVac N.V.?
  • What is CureVac N.V. quarterly EBIT year-on-year change?
  • What is CureVac N.V. TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for CureVac N.V.?
  • What is CureVac N.V. TTM EBIT year-on-year change?

What is CureVac N.V. annual earnings before interest & taxes?

The current annual EBIT of CVAC is $206.60M

What is the all time high annual EBIT for CureVac N.V.?

CureVac N.V. all-time high annual earnings before interest & taxes is $206.60M

What is CureVac N.V. annual EBIT year-on-year change?

Over the past year, CVAC annual earnings before interest & taxes has changed by +$488.04M (+173.41%)

What is CureVac N.V. quarterly earnings before interest & taxes?

The current quarterly EBIT of CVAC is -$57.83M

What is the all time high quarterly EBIT for CureVac N.V.?

CureVac N.V. all-time high quarterly earnings before interest & taxes is $443.54M

What is CureVac N.V. quarterly EBIT year-on-year change?

Over the past year, CVAC quarterly earnings before interest & taxes has changed by +$25.98M (+31.00%)

What is CureVac N.V. TTM earnings before interest & taxes?

The current TTM EBIT of CVAC is $252.33M

What is the all time high TTM EBIT for CureVac N.V.?

CureVac N.V. all-time high TTM earnings before interest & taxes is $252.33M

What is CureVac N.V. TTM EBIT year-on-year change?

Over the past year, CVAC TTM earnings before interest & taxes has changed by +$574.49M (+178.32%)
On this page